TD Cowen analyst Bill Katz raised the firm’s price target on CME Group (CME) to $340 from $328 and keeps a Buy rating on the shares. The firm adjusted targets in the asset manager, broker dealers and exchanges group as part of a Q1 preview.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CME:
- CME Group resumed with a Market Perform at Keefe Bruyette
- CME Group reports Q1 international ADV 11.4M contracts, up 30%
- CME Group price target raised to $344 from $312 at Barclays
- Crypto Currents: Corporate bitcoin buying outpaces new supply by 62%
- CME Group launches Avalanche and Sui futures